Caris Life Sciences, Inc. (CAI)
17.61
-0.93
(-5.02%)
USD |
NASDAQ |
Nov 20, 16:00
17.92
+0.31
(+1.76%)
After-Hours: 20:00
Caris Life Sciences Gross Profit (TTM) : 724.14M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 724.14M |
| June 30, 2026 | 689.36M |
| March 31, 2026 | 623.45M |
| December 31, 2025 | 539.17M |
| September 30, 2025 | 388.96M |
| June 30, 2025 | 285.86M |
| Date | Value |
|---|---|
| March 31, 2025 | 209.73M |
| December 31, 2024 | 178.78M |
| September 30, 2024 | 108.08M |
| June 30, 2024 | 63.67M |
| March 31, 2024 | 26.11M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Natera, Inc. | 1.876B |
| Myriad Genetics, Inc. | 519.00M |
| BioRestorative Therapies, Inc. | 0.119M |
| CareDx, Inc. | 350.70M |
| Exagen, Inc. | 42.46M |